Shore Cancer Center Receives Re-Accreditation from the Commission on Cancer with Zero Deficiencies

Shore Medical Center is proud to announce that its Cancer Center, a member of the Penn Cancer Network, has been re-accredited by the Commission on Cancer (CoC) with zero deficiencies. The CoC, a voluntary quality program of the American College of Surgeons (ACS), focuses on maintaining the highest standards of quality and safety in Oncology Programs.

To achieve CoC accreditation, cancer programs must meet 34 quality of care standards established by the CoC, undergo comprehensive evaluations every three years, and consistently deliver exceptional patient-centered care across multiple disciplines.

The recent re-accreditation of Shore Cancer Center is a remarkable and challenging achievement. This success is a testament to the dedication and collaborative efforts of the entire Cancer Center team, spanning numerous disciplines. Each individual's contribution played a vital role in meeting and surpassing the CoC's rigorous standards.

Notably, Kimberly Kaczmarski, MBA, ROCC, RT (R)(T)(CT), Manager of Radiation Oncology, and Dr. James Pond, Pathologist and Cancer Committee Chair, deserve special recognition for their exceptional work in spearheading the CoC accreditation process and providing guidance throughout the entire journey. Their expertise and commitment have been instrumental in the Cancer Center's continued pursuit of excellence.

"We are thrilled to announce our re-accreditation by the Commission on Cancer with zero deficiencies," said Matthew Piskun, PharmD, MBA, Director of Pharmacy, Oncology and Infusion Services at the Shore Cancer Center. "This achievement showcases our unwavering dedication to delivering outstanding care to our patients and upholding the highest standards of quality and safety. We extend our sincere appreciation to every individual who contributed to this success and reaffirm our commitment to providing comprehensive, patient-centered care."

Shore Cancer Center remains committed to advancing cancer care, staying at the forefront of medical advancements, and continuously improving patient outcomes. This re-accreditation serves as a testament to their ongoing efforts and dedication to excellence.

For more information about Shore Cancer Center and its services, please visit or call 609-653-3585.